Current status on the development of pseudoviruses for enveloped viruses
Q Li, Q Liu, W Huang, X Li… - Reviews in medical …, 2018 - Wiley Online Library
Emerging and reemerging infectious diseases have a strong negative impact on public
health. However, because many of these pathogens must be handled in biosafety level, 3 or …
health. However, because many of these pathogens must be handled in biosafety level, 3 or …
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS …
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS …
Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection
Recent reports highlight a new clinical syndrome in children related to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2)—multisystem inflammatory syndrome in …
respiratory syndrome coronavirus 2 (SARS-CoV-2)—multisystem inflammatory syndrome in …
Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays
SARS-CoV-2 enters cells using its Spike protein, which is also the main target of neutralizing
antibodies. Therefore, assays to measure how antibodies and sera affect Spike-mediated …
antibodies. Therefore, assays to measure how antibodies and sera affect Spike-mediated …
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
Human monoclonal antibodies are safe, preventive, and therapeutic tools that can be rapidly
developed to help restore the massive health and economic disruption caused by the …
developed to help restore the massive health and economic disruption caused by the …
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
COVID-19 vaccine design and vaccination rollout need to take into account a detailed
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 …
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 …
Viral infection neutralization tests: A focus on severe acute respiratory syndrome‐coronavirus‐2 with implications for convalescent plasma therapy
Viral neutralization tests (VNTs) have long been considered old‐fashioned tricks in the
armamentarium of fundamental virology, with laboratory implementation for a limited array of …
armamentarium of fundamental virology, with laboratory implementation for a limited array of …
The polybasic cleavage site in SARS-CoV-2 spike modulates viral sensitivity to type I interferon and IFITM2
H Winstone, MJ Lista, AC Reid, C Bouton… - Journal of …, 2021 - Am Soc Microbiol
The cellular entry of severe acute respiratory syndrome-associated coronaviruses types 1
and 2 (SARS-CoV-1 and-2) requires sequential protease processing of the viral spike …
and 2 (SARS-CoV-1 and-2) requires sequential protease processing of the viral spike …
The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection
L Henss, A Auste, C Schürmann… - Journal of General …, 2021 - microbiologyresearch.org
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has caused a
pandemic with tens of millions of cases and more than a million deaths. The infection causes …
pandemic with tens of millions of cases and more than a million deaths. The infection causes …
[HTML][HTML] A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination
J Seow, H Khan, A Rosa, V Calvaresi, C Graham… - Cell Reports, 2022 - cell.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike is the target for
neutralizing antibodies elicited following both infection and vaccination. While extensive …
neutralizing antibodies elicited following both infection and vaccination. While extensive …